Novanta (NASDAQ:NOVT) Updates FY 2026 Earnings Guidance

Novanta (NASDAQ:NOVT) updated its FY 2026 earnings guidance on Wednesday morning. The company provided EPS guidance of 3.680-3.740 for the period, compared to the consensus estimate of 3.590. The company issued revenue guidance of $1.1 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion. Novanta also updated its Q3 2026 guidance to 0.950-1.000 EPS.

Novanta Stock Performance

Novanta stock traded down $6.37 during midday trading on Wednesday, reaching $153.12. The stock had a trading volume of 548,040 shares, compared to its average volume of 466,732. The firm’s 50-day moving average price is $154.02 and its 200 day moving average price is $141.07. The firm has a market capitalization of $5.78 billion, a PE ratio of 110.96 and a beta of 1.68. Novanta has a 12 month low of $98.27 and a 12 month high of $171.85. The company has a quick ratio of 2.69, a current ratio of 3.56 and a debt-to-equity ratio of 0.15.

Novanta (NASDAQ:NOVT) last issued its quarterly earnings data on Wednesday, August 5th. The technology company reported $0.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.83 by $0.06. The company had revenue of $265.81 million for the quarter, compared to the consensus estimate of $262.30 million. Novanta had a return on equity of 12.06% and a net margin of 5.35%.Novanta has set its FY 2026 guidance at 3.680-3.740 EPS and its Q3 2026 guidance at 0.950-1.000 EPS. As a group, research analysts predict that Novanta will post 3.59 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on NOVT shares. Weiss Ratings reiterated a “hold (c-)” rating on shares of Novanta in a report on Wednesday, July 15th. Wall Street Zen lowered Novanta from a “buy” rating to a “hold” rating in a research report on Saturday. Finally, Robert W. Baird set a $180.00 price target on shares of Novanta in a research note on Tuesday, June 9th. One research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $180.00.

Insider Buying and Selling at Novanta

In related news, CEO Matthijs Glastra sold 6,500 shares of the firm’s stock in a transaction that occurred on Thursday, July 2nd. The shares were sold at an average price of $161.13, for a total transaction of $1,047,345.00. Following the transaction, the chief executive officer owned 29,761 shares of the company’s stock, valued at approximately $4,795,389.93. This trade represents a 17.93% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.20% of the stock is owned by company insiders.

Institutional Trading of Novanta

A number of institutional investors and hedge funds have recently modified their holdings of NOVT. Corient Private Wealth LLC acquired a new position in shares of Novanta in the 4th quarter worth approximately $275,000. Invesco Ltd. boosted its stake in Novanta by 9.0% in the fourth quarter. Invesco Ltd. now owns 68,089 shares of the technology company’s stock valued at $8,102,000 after acquiring an additional 5,600 shares during the last quarter. Alberta Investment Management Corp bought a new stake in shares of Novanta in the 4th quarter valued at about $1,285,000. Mercer Global Advisors Inc. ADV bought a new position in Novanta during the fourth quarter worth about $314,000. Finally, Empowered Funds LLC increased its position in shares of Novanta by 16.7% during the fourth quarter. Empowered Funds LLC now owns 7,888 shares of the technology company’s stock worth $939,000 after acquiring an additional 1,128 shares in the last quarter. 98.35% of the stock is currently owned by institutional investors.

About Novanta

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.